0 CHECKOUT

PRODUCT FILTERS

REGION

3
1
1
1
1

COUNTRY

1
1

CATEGORIES

  • 6
  • 3
  • 2
  • 1

PRICE

6
6
9
12

PUBLISHED

0
1
2
12

PRODUCT TYPE

10
2

Search for: "iNova Pharmaceuticals (Australia) Pty Limited-Company Report"

12 Products

Impact of Patent Expiration on Key Drugs Categories for 2012-2016 - A Survey Report

TechNavio's analysts have conducted a survey on Impact of Patent Expiration on Key Drugs Categories for 2012-2016. The survey assessed the Impact of Patent Expiration on several key drugs categories...

Published:  November 2012
Price:  From

Respiratory Tract Inflammatory Disorders - Pipeline Review, H2 2012

Respiratory Tract Inflammatory Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Respiratory Tract Inflammatory Disorders - Pipeline Review, H2 2012', provides an overview of...

Published:  November 2012
Price:  From

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2012

Chronic Obstructive Pulmonary Disease (COPD) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2012', provides an overview...

Published:  August 2012
Price:  From

Bronchitis - Pipeline Review, H2 2012

Bronchitis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Bronchitis - Pipeline Review, H2 2012', provides an overview of the Bronchitis therapeutic pipeline. This report provides information...

Published:  August 2012
Price:  From

Biopharmaceutical Contract Manufacturing Market, 2015 - 2025

Characterized by a rapidly expanding product pipeline and a capital intensive manufacturing business, the biopharmaceutical market is witnessing a growing trend towards contract manufacturing. In addition...

Published:  May 2015
Price:  From

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2012

Chronic Obstructive Pulmonary Disease (COPD) – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2012', provides an overview...

Published:  February 2012
Price:  From

Bronchitis - Pipeline Review, H2 2011

Bronchitis - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Bronchitis - Pipeline Review, H2 2011', provides an overview of the Bronchitis therapeutic pipeline. This report provides information...

Published:  September 2011
Price:  From

Bronchitis - Pipeline Review, H1 2012

Bronchitis – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Bronchitis - Pipeline Review, H1 2012', provides an overview of the Bronchitis therapeutic pipeline. This report provides information...

Published:  February 2012
Price:  From

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2011

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2011', provides an overview...

Published:  September 2011
Price:  From

Asthma Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Asthma Therapeutics in US$ Million The major therapeutic segments analyzed are Inhaled corticosteroids, Short acting beta agonists, Long acting beta agonists,...

Published:  October 2006
Price:  From

Global Corporate Debt Demand Declines To $57 Trillion As Credit Risk Concentrates In China, U.S. Jul 15

Abstract MELBOURNE (Standard & Poor's) July 16, 2015--Global corporate debt demand will peak at an estimated $57 trillion by 2019, a decline of 4% from last year's projection, according to an annual...

Published:  July 2015
Price: 

Credit Trends: Potential Bond Rating Upgrades: Pearl Fishing Among Oysters Sep 03

Abstract More entities appear well placed for potential upgrades compared with four months ago, said a report released today from Standard & Poor's Ratings Services, indicating that the trough in this...

Published:  September 2003
Price: 
Loading Indicator

Our Clients

  • Innocent Drinks Ltd.
  • Groupe Danone
  • Cisco Systems, Inc.
  • The World Bank Group
  • Swarovski AG
  • Owens Corning Corporation
  • Swiss Reinsurance Company Ltd.